-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on IDEAYA Biosciences, Raises Price Target to $66

Benzinga·11/05/2026 23:37:30
Diffusion vocale
Citigroup analyst Yigal Nochomovitz maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $65 to $66.